Through the examination of tumor hypoxia by 18FMISO (Figure 5(D,E), p < .05) and HIF-1α (Figure 6(A,C-left), p < .05), we also found that ES/HA-Tyr + RT can more effectively reduce hypoxia than either monotherapy in tumor tissues. The gene discussed is HIF1A; the disease is neoplasm.